Implantable technologies : peptides and small molecules drug delivery [E-Book] / editor: Ved Srivastava
Implantable technologies allow for a sustained control over the release of pharmaceuticals into the bloodstream thereby achieving a controlled concentration with the potential to minimise side-effects while increasing patient compliance. Significant progress has been made in various alternative impl...
Saved in:
Full text |
|
Personal Name(s): | Srivastava, Ved, editor |
Imprint: |
Cambridge :
Royal Society of Chemistry,
2022
|
Physical Description: |
1 online resource (302 pages) |
Note: |
englisch |
ISBN: |
9781839164958 |
DOI: |
10.1039/9781839164958 |
Series Title: |
/* Depending on the record driver, $field may either be an array with
"name" and "number" keys or a flat string containing only the series
name. We should account for both cases to maximize compatibility. */?>
Drug development and pharmaceutical science
|
Subject (LOC): |
- Status of Implantable and Long-acting Injectable Technologies
- Developing Complex Dosage Forms of Long-acting Biologics for the Eye: Current State, Challenges, and Opportunities
- Monolithic Devices for Sustained Delivery of Protein Therapeutics for Ocular Disease
- Sustained Delivery of Ocular Protein Therapeutics
- Development of Risperidone Implant Formulations (DLP-114) for Long-term Maintenance Treatment of Schizophrenia
- In-line Extrusion Process and Product Evaluation of ProNeura® by Near-infrared Spectroscopy
- Addressing Immunogenicity for Implantable Drug-delivery Devices and Long-acting Injectables, Including Pharmacokinetic and Pharmacodynamic Correlations
- Characterization Methods for Parenteral Peptide Controlled Release Drug Delivery Systems
- Parenteral Delivery of Therapeutic Proteins, Peptides and Small Molecules Using Biodegradable Silica
- Development of User-initiated Vaginal Dosage Forms
- Three-dimensional Printed Implantable Products